Critically, Miedema et al. (2010) [20] emphasized that while their IL-8/PCT combination showed promise for risk stratification in febrile neutropenia, the model’s clinical utility was limited by IL-8’s lack of specificity for bacterial infection, particularly given its elevation in mucositis, and stressed the need for further validation studies. The gene discussed is CALCA; the disease is bacterial infectious disease.